FTC is geared up to unhesitantly scrutinize and challenge pharmaceutical conglomerates that could entrench their monopolies. ...
Healthcare & Pharmaceutical
Novartis has named the intended new board members of Sandoz, the generics business it plans to spin off to shareholders later this year. The move is a key step in th...
While the US IPO market has been quite quiescent in 2022, J&J’s Kenvue is expected to renew the hopes of other companies that were holding their IPOs in abeyan...
Kenvue’s IPO Roadshow involves inviting potential investors to inveigle them into pumping funds ahead of the offering. ...
Even with the scandalmongering, J&J is audacious to not admit to any wrongdoing in the proposed settlement, maintaining that they stand behind the safety of John...
Glenn’s Departure Sinks Novavax Stock – Novavax’s stock experienced a minor setback on Thursday as the biotech announced the official departure of ...
2023 appears to be a transitional year for the global economy. With changing trends and demands of consumers, companies that focus on researching and analyzing mark...
Testimonials are effective tools in convincing customers that the people marketing them are regular people and seem more trustworthy. ...
It is clear that the healthcare sector is booming and set for change. With Verily’s recent fundraising, the company will also look to foster strategic partnerships...
